SEARCH

SEARCH BY CITATION

References

  • 1
    Swedish Cancer Society and Swedish National Board of Health and Welfare: Breast-cancer screening with mammography in women aged 40–49 years. Int J Cancer 1996; 68: 693699.
  • 2
    NCI plans conference to reconsider breast cancer screening in women 40 to 49. The Cancer Letter 1996; 22: 12.
  • 3
    Report of the Consensus Development Conference Panel on Breast Cancer Screening for Women Ages 40–49, January 21–23, 1997. Bethesda, MD, National Institutes of Health, 1997.
  • 4
    Shapiro S, Venet W, Strax P, et al: Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986. Baltimore, Johns Hopkins University Press, 1988.
  • 5
    Ries LAG, Kosary C, Hankey BF, et al: SEER Cancer Statistics Review, 1973–1993. Bethesda, MD, National Cancer Institute, 1996.
  • 6
    Hendrick RE, Smith RA, Rutledge JH, et al: Benefit of screening mammography in women ages 40–49: A meta-analysis of new randomized controlled trial results, in NIH Consensus Development Conference: Breast Cancer Screening for Women Ages 40–49, Program and Abstracts. Bethesda, MD, National Institutes of Health, 1997.
  • 7
    Bjurstam N, Bjornel L, Duffy SW: The Gothenburg breast cancer screening trial: Results from 11 years follow-up, in NIH Consensus Development Conference: Breast Cancer Screening for Women Ages 40–49, Program and Abstracts. Bethesda, MD, National Institutes of Health, 1997.
  • 8
    Andersson I: Results from the Malmo breast screening trial, in NIH Consensus Development Conference: Breast Cancer Screening for Women Ages 40–49, Program and Abstracts. Bethesda, MD, National Institutes of Health, 1997.
  • 9
    Tabar L, Duffy S, Chen H: Re: quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 1996; 5253. Letter.
  • 10
    Duffy SW, Chen HH, Tabar L, et al: Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40–49. Int J Epidemiol 1996; 25: 8: 11391145.
  • 11
    Tabar L, Fagerberg G, Chen HH, et al: Tumour development, histology and grade of breast cancers: Prognosis and progression. Int J Cancer 1996; 66: 413419.
  • 12
    Paci E, Duffy SW: Modelling the analysis of breast cancer screening programmes: Sensitivity, lead time and predictive value in the Florence District Programme (1975–1986). Int J Epidemiol 1991; 20: 852858.
  • 13
    Linver MN: Mammography outcomes in a practice setting by age: Prognostic factors, sensitivity, and positive biopsy rate, in NIH Consensus Development Conference: Breast Cancer Screening for Women Ages 40–49, Program and Abstracts. Bethesda, MD, National Institutes of Health, 1997.
  • 14
    Sickles EA: Screening outcomes: Clinical experience with service screening using modern mammography, in NIH Consensus Development Conference: Breast Cancer Screening for Women Ages 40–49, Program and Abstracts. Bethesda, MD, National Institutes of Health, 1997.
  • 15
    Lee NC: Results from the National Breast and Cervical Cancer Early Detection Program, 19911995, in NIH Consensus Development Conference: Breast Cancer Screening for Women Ages 40–49, Program and Abstracts. Bethesda, MD, National Institutes of Health, 1997.